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Abstract
Background: Treatment delay in first episode psychosis is common. As general practitioners are
the first point of contact for many individuals with first episode psychosis, they are well placed to
detect the early symptoms and make urgent referrals to specialist secondary care services.
However, early psychosis is often difficult to detect. The primary objective of the Redirect trial is
to estimate whether an educational intervention targeted at general practitioners increases the
general practitioner referral rate of young people with first episode psychosis to Early Intervention
Services.
Methods/design: This paper describes the design of a stratified-cluster randomised controlled
trial of an educational intervention on first episode psychosis in primary care. The primary outcome
is the number of general practitioner referrals of young people with first episode psychosis to Early
Intervention Services. Secondary outcomes are duration of untreated psychosis, time to recovery,
use of the Mental Health Act, and general practitioner consultation rate. Young people with first
episode psychosis referred to Early Intervention Services will be recruited over a two-year period
from 1 March 2004. Seventy-eight out of 89 eligible general practices were recruited. The
educational intervention has been implemented and evaluated by general practitioners. The
education was well received and considered relevant to clinical practice by the general
practitioners.
Discussion:  The results suggest that the recruitment strategy and implementation of the
educational intervention are feasible and acceptable in a primary care setting. The Redirect trial will
provide robust information about the efficacy of an evidence-based complex educational
intervention targeted at general practitioners on referral rates of young people with first episode
psychosis to Early Intervention Services.
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Background
Studies have shown that young people with first episode
psychosis (FEP) experience lengthy delays between the
onset of psychotic symptoms and receipt of treatment
[1,2]. The average period from first onset of psychosis to
initiation of adequate treatment (duration of untreated
psychosis, or DUP) is one to two years [3]. During this
untreated period, irreversible biological, social and psy-
chological damage may take place [2], and a delay in treat-
ment is associated with poorer short-term outcome and
slower recovery [1]. Early intervention in this 'critical
period' [4] is therefore important for both patients and
families. Strategies to reduce DUP include providing early
access to specialist mental health services, such as early
intervention services (EIS), and improving recognition of
FEP by educating primary care professionals [5].
The integration of mental health and primary care services
around the world, in developed as well as developing
countries, has been widely advocated [6-10]. As part of
this process, a range of national and international policy
developments have occurred, with the aim of improving
the identification and management of mental illness in
primary care [11-18]. In the United Kingdom (UK), for
example, standards two and three of the Mental Health
National Service Framework [16] require primary care to
provide effective identification, assessment, and treat-
ment of people with mental illness, including appropriate
early referral to specialist services. National guidance on
schizophrenia [19] and the inclusion of mental health
indicators for care of people with serious mental illness in
the new GP contract [20] further strengthen the role and
responsibilities of primary care by encouraging a more
systematic approach to care, including the use of proto-
cols and referral guidelines.
As part of the UK policy response to improve the early
detection and treatment of FEP, in 2000, the NHS Plan
prioritised the development of 50 "early intervention"
teams across England and Wales to provide specialist
mental health services for all young people aged 14–35
with a FEP [21]. General practitioners (GPs) are well
placed to play a greater role in the identification and man-
agement of FEP, as they are usually the first point of
patient contact [22], and GP involvement in the manage-
ment of psychosis is associated with reduced use of the
Mental Health Act[23]. However, primary care health pro-
fessionals cannot refer to EIS without knowledge of FEP
and an understanding of the EIS referral system.
The limited evidence base in this area has, however, con-
sistently shown a need for improvement in the detection
and management of FEP in primary care. Early detection
is a challenge for many GPs, since psychosis does not
present in "neat packages" and can take several months to
emerge [24]. The prodrome largely consists of non-spe-
cific psychological and social disturbances of varying
intensity, which is possibly why GPs experience difficulty
in distinguishing FEP from normal adolescent behaviour
[25,26]. GPs also experience uncertainty about how to
identify FEP, treat FEP appropriately, and access specialist
mental health services [25,26]. These data suggest the
importance of training GPs to improve early detection
and management of FEP to reduce the delay between
onset of symptoms and initiation of treatment.
Recent reports indicate that promoting early detection in
a community based setting can be successful [27,28]. A
Scandinavian community education programme in the
identification of FEP, for example, led to reduction in
DUP from 1.5 years (mean) to 0.5 years [27,29]. How-
ever, the Redirect trial is the first randomised controlled
trial aimed at educating GPs about FEP.
The Redirect study team designed an evidence based
"complex" educational intervention that addressed the
knowledge, skills, and attitudes of GPs about FEP. A
refresher educational intervention was planned and
implemented to reinforce knowledge and skills acquired
in the initial educational intervention and to promote
positive attitudes towards young people with FEP, given
that most GPs see only one or two new people with FEP
each year. The intervention is being used in a stratified-
cluster randomised controlled trial to evaluate the effect
of the educational intervention on GP referral rates of
young people with FEP to EIS.
Study aims
The primary aim of the Redirect trial is to estimate
whether an educational intervention targeted at GPs
increases the GP referral rate of young people with FEP to
EIS.
Methods/design
Setting, eligibility and recruitment of practices
Ethics Committee approval was obtained from Sandwell
& West Birmingham, South Birmingham and East Bir-
mingham Research Ethics Committees. The Redirect trial
was conducted in three Primary Care Trusts (PCTs) within
Birmingham in the UK, which encompass the areas of
Aston, Handsworth, Ladywood, Nechells, Sandwell,
Small Heath, Sparkbrook, Sparkhill, Soho, and Wash-
wood Heath. Eighty-nine general practices within these
three PCTs with the authority to refer to EIS were eligible
for inclusion to the trial. These included 74 general prac-
tices located within the catchment area of the Heart of Bir-
mingham Teaching PCT (HoB tPCT), 14 practices within
the catchment area of Eastern Birmingham PCT, and one
practice within the catchment area of South Birmingham
PCT.BMC Health Services Research 2005, 5:19 http://www.biomedcentral.com/1472-6963/5/19
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Practice recruitment was facilitated by a letter to each prac-
tice from the study team and from the Chief Executive of
the HoB tPCT, presentations by the second author at the
HoB tPCT protected "learning time" sessions (where the
PCT enabled GPs to close their practices and attend by
paying for locum doctor cover) and an evening meeting
attended by the practices within the catchment area of
Eastern Birmingham PCT. Practices received a quarterly
newsletter post randomisation during the study period.
The newsletter was designed to encourage continued
interest and participation in the Redirect trial.
Consecutive patients with FEP who are referred by the
Redirect trial GPs to the two Birmingham EIS over a two-
year period from 1 March 2004 to March 2006 are eligible
for inclusion in the study. Patients must also be aged
between 14 to 30 years, in line with the Mental Health
Policy implementation guide for Early Intervention [30],
and have an ICD-10 [31] chart diagnosis of schizophrenia
or related disorders (F20, F22, F23, F25, F28, F31). The
exclusion criteria are patients with a primary diagnosis of
substance use disorder, mood disorder, or organic mental
disorder, current criminal proceedings, serious concurrent
physical illness, institutional residence, learning disabil-
ity, or inability to provide informed consent (see Table 1).
Design and randomisation of general practices
The study is a stratified-cluster randomised controlled
trial design [32,33]. The cluster design at practice level
reduces the risk that the educational intervention deliv-
ered to GPs will be contaminated by interaction between
GPs within a single practice. Practices were randomly allo-
cated after stratifying by list size (more or less than 3,500
patients) and PCT (HoB or not). These strata were used to
ensure balance on the number of practices where no refer-
rals of FEP might occur and to account for the differential
prevalence of FEP across the study area. Practices were ran-
domly allocated to either the intervention (39 practices)
or control group (39 practices) by NF, who was blind to
practice identity, using computer generated random num-
bers. Figure 1 shows the trial profile summarising practice
recruitment and retention.
The educational intervention
General practices were randomised to receive either the
educational intervention on detecting FEP (intervention
practices) or to an alternative educational session on cog-
nitive behaviour therapy for depression (control prac-
tices) to control for any possible "attention" effect. In
developing the educational intervention, the study team
followed the five phases of the framework for the design
and evaluation of complex health interventions proposed
by the Medical Research Council and Campbell et
al[34,35], and incorporated evidence from systematic
reviews and guidelines on changing professional practice
[36,37]. A brief 17-minute video depicting GP consulta-
tions with young people with FEP was shown to all mem-
bers of the intervention practices, and the trial educators
(first and second authors) then led a 15-minute question
and answer session. The video addressed GP attitudes and
negative stereotypes of people with FEP and also included
elements of didactic factual teaching on, for example,
links between drug use and psychosis, key warning symp-
toms of psychosis, including recognition of negative
symptoms, and how to ask questions about sensitive
issues such as hearing voices and suicidal ideas. A booklet
summarising the content of the video and a two-sided
laminated 'tip' sheet on FEP symptoms and useful ques-
tions to ask patients were also given to all intervention
group GPs.
All intervention GPs viewed the video between November
2003 and January 2004. Twenty-one general practices
(54%) viewed the video during 'protected learning' time
and 18 general practices (46%) viewed the video at their
premises during their own time. At the end of the educa-
tion session, GPs were asked to evaluate three specific ele-
ments of the video on a five-point rating scale: key
information on FEP, useful questions to ask during con-
sultations, and personal confidence in detecting FEP. GPs
Table 1: Patient inclusion and exclusion criteria
Inclusion criteria
• First episode psychosis
• Aged 14–30 years
• (ICD-10: F20, 22, 23, 25, 28, 31)
• Living within the catchment area
Exclusion criteria
Patients with a history of prior psychosis in receipt of antipsychotic 
medication
Patients with a primary diagnosis of substance use disorder or organic 
disorder
Institutional residence
Patients with learning disability
Inability to provide informed consent
Patients with current criminal proceedings
Patients with serious concurrent physical illnessBMC Health Services Research 2005, 5:19 http://www.biomedcentral.com/1472-6963/5/19
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were also asked what they found most and least useful
about the video.
Refresher educational sessions for intervention practices
were conducted in small groups, with training events
spread over three days from 29 June 2004 to 1 July 2004.
The refresher training consisted of personal testimonies
from two service users, a service user personal testimony
presented in a brief 10 minute video, and a presentation
from an EIS representative on the EIS acceptance criteria
and referral process. GPs were again asked to provide feed-
back on specific components of the training using a simi-
lar five-point rating scale.
Outcomes
The primary outcome will be measured at practice level
(unit of randomisation) by assessing the difference in the
number of referrals of young people with FEP to second-
ary care services between study groups. Secondary out-
comes are DUP, time to recovery, use of the Mental Health
Act (at patient level), and GP consultation rate (at practice
level). Instruments used in the evaluation are summarised
in Table 2.
Baseline assessments and follow-up
The two field researchers are approaching all new FEP
referrals to the two EIS in inner-city Birmingham to seek
informed consent and entry to the trial. Patients meeting
eligibility criteria and providing written informed consent
are interviewed by the research team at baseline and at a
four-month follow-up interview. At baseline, data are col-
lected on socio-demographic factors and psychosis
symptoms during the past month using the Schedules for
Clinical Assessment in Neuropsychiatry (SCAN) version
2.0 [38]. The SCAN is a set of instruments used to assess,
measure, and classify psychopathology associated with
adult major psychiatric disorders. Part two, which
includes psychosis disorders, was felt most applicable for
use in this study.
Insight
Insight is measured at baseline and at four months using
the Insight Scale [39], an eight-item self-report scale
designed to be sensitive to changes in levels of insight. The
scale captures each of three widely accepted dimensions of
insight: awareness of illness, perceived need for treatment,
and ability to re-label symptoms as pathological. Higher
scores indicate greater levels of insight. The psychometric
properties of the scale are excellent and it is a widely used
scale in psychosis research.
Early signs
The Early Signs Scale [40] is used at baseline and at four
months to assess at risk mental states and provide a meas-
ure of clinical recovery, determined by ratings of <20
GP enrolment, randomisation and flow of practices through  trial Figure 1
GP enrolment, randomisation and flow of practices through 
trial
Refresher education during
June/July 2004
Data collected from patients for
two years after education
intervention
(March 2004 to March 2006)
Withdrawn from trial
(1 single handed GP
practice)
78 practices agreed to participate
78 practices randomised
Stratified by list size and PCT
39 practices allocated to control
89 eligible practices invited to
participate
11 practices declined
39 practices allocated to
intervention
Intervention beginning between
November 2003 and January
2004
Alternative education beginning
between November and
December 2003
Data collected from patients for
two years after education
intervention
(March 2004 to March 2006)
Table 2: Summary of research assessments
Instrument Baseline Follow-up
SCAN [38] x
PANSS [41] x x
Insight Scale [39] x x
Early Signs Scale [40] x x
DUP [42] x
PAS [44] x
Encounter Form [45] xBMC Health Services Research 2005, 5:19 http://www.biomedcentral.com/1472-6963/5/19
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(including <10 on scales of incipient psychosis and disin-
hibition combined).
Psychotic symptoms
Psychotic symptoms are measured at baseline and at four
months with the Positive and Negative Syndrome Scale
(PANSS; [41]). The PANSS is a 30-item semi-structured
interview that consists of seven items assessing positive
symptoms (e.g., hallucinations, delusions, conceptual
disorganisation), seven items assessing negative symp-
toms (blunted affect, difficulty in abstract thinking) and
16 items assessing global psychopathology (e.g., depres-
sion, anxiety, disorientation). Items are scored between
one (not present) and seven (severe). The PANSS is a
widely used, valid and reliable measure of mental state.
Duration of untreated psychosis (DUP)
At the four-month follow-up assessment, DUP is assessed
with a semi-structured interview following the model of
Beiser [42]. DUP is defined as the time interval between
the onset of psychotic symptoms and the initiation of
treatment, and calculated according to a stringent proto-
col adapted from criteria developed by Larsen [43].
Premorbid functioning
Premorbid functioning is assessed at the four-month fol-
low-up assessment with the Premorbid Adjustment Scale
(PAS) [44]. The "premorbid" period is defined as the
period that ends six months before there is any evidence
of psychotic symptoms or first psychiatric hospital admis-
sion. The PAS measures four areas of development: (1)
sociability-isolation, (2) peer relationships, (3) ability to
function outside of the nuclear family, and (4) capacity to
form intimate socio-sexual ties at each of four life stages:
childhood (up to age 11), early adolescence (12–15
years), late adolescence (16–18 years), and adulthood (19
years and older). The PAS includes a 'general' scale that
measures the highest level of functioning attained by the
individual before becoming ill. For example, if an individ-
ual was aged 20 at the time of completion, but experi-
enced psychotic symptoms at the age of 17, the adult scale
would not be completed. Items are scored on a Likert-type
scale of zero to six, with lower scores denoting healthier
functioning and higher scores indicating greater dysfunc-
tional adjustment.
Pathways to care
Pathways to care is measured at four months follow-up
with the Encounter form [45]. This instrument is also used
to determine retrospective GP consultation and referral
rates and use of the Mental Health Act from primary care
records.
Reliability of diagnoses and PANSS scores
The two field researchers attended a five day, WHO-certi-
fied training course in using the SCAN and a local two day
training course in administering the PANSS to the training
standard of interrater concordance between field research-
ers and trainers. The interrater reliability method used was
descriptive, according to agreement within one rating
point on the positive and negative subscales and within
three rating points on the general psychopathology sub-
scale. To achieve interrater reliability on the total PANSS
scores, agreement between the field researcher and trainer
had to be within the 80% range. Throughout the study, we
will conduct interrater reliability maintenance checks of
the SCAN and PANSS, with live interviews, to avoid drift
in scoring across time.
Sample size
The primary outcome of the study is the difference
between the randomised groups on the number of young
people with FEP referred to EIS during the study period,
analysed on the basis of intention to treat. As the GPs,
rather than their patients, are the subjects of the study, the
statistical analysis and thus power calculation accounts
for this.
Assuming the standard critical value for α (2 sided p =
0.05), and further that, on average, two referrals will be
made in control practices in the study period, and that the
variance for between practice variability is one, the study
has 80% power (1-β) to detect a mean difference of 1.2
referrals between intervention and control practices, and
90% power (1-β) to detect a mean difference of 1.4
referrals.
As this study is the first randomised trial of an educational
intervention in primary care which aims to influence
detection and referral practice of GPs, we have no data
upon which to base power calculations for the secondary
outcome measures which may be considered exploratory
(and which will provide relevant data for any future
studies).
Blinding
The participants and field researchers assessing patient
outcomes were blinded to the identity of practices that
participated in the educational intervention. Statistical
analysis follows a pre-specified analysis plan.
Statistical analysis plan
The effect of the intervention on the primary outcome will
be estimated using a non linear mixed model, where the
number of referrals per practice will be modelled using
Poisson error, and overdispersion (extra Poissonian varia-
bility) will be accounted for by defining the practice as aBMC Health Services Research 2005, 5:19 http://www.biomedcentral.com/1472-6963/5/19
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random effect [46]. Analyses will be conducted using Proc
Nlmixed in the SAS statistical programme, version 9 [47].
Secondary outcomes will be analysed using a mixed mod-
elling strategy, accounting for between practice variability
by defining practices as random effects. As the subject of
the experiment is the practice rather than the patient, the
denominator degrees of freedom for the analysis will be
derived from that stratum.
Practices recruited
A total of 78 practices out of 89 eligible practices were
recruited between July 2003 and October 2003 (Figure 1).
The 11 practices that declined to participate cited staffing
problems and/or time pressures as the main reasons for
non-participation.
Characteristics of participating practices
The practice characteristics of participating and non-par-
ticipating practices are summarised in Table 3 and suggest
that the participating practices are representative and that
the randomisation, after stratification by practice list size
and PCT, has been effective.
Attendance at education intervention and GP feedback
All 39 practices (100%) were represented by one or more
GPs at the initial video-based education sessions. Feed-
back forms on the video were completed by 53 of the 62
GPs (85% response rate). The majority of GPs who partic-
ipated in the video training agreed or strongly agreed that
the video helped them to identify key information to
assist their consultations (89%), highlighted useful ques-
tions to ask patients (81%), and would improve their con-
fidence in their ability to detect FEP (66%).
Attendance at refresher education and GP feedback
Thirty-five GPs, representing 26 practices (66.7%),
attended the refresher education session and one practice
(eight GPs) was visited by the first author. Feedback was
obtained from 31 GPs (response rate 89%). Training was
perceived as effective in raising awareness of FEP (87%)
and the referral process to early intervention services
(84%), and GPs reported that the training was relevant
(84%), enjoyable (87%), and informative (84%).
Discussion
The Redirect trial has been designed to evaluate the effec-
tiveness of an educational intervention targeted at GPs on
the detection of young people with FEP on referrals to EIS.
The educational intervention was designed to be feasible
to implement in a busy primary care setting and accepta-
ble to GPs. Recruitment of practices into the trial itself was
helped by ensuring that GP time and involvement in the
study was kept to a minimum, in recognition of the work-
load pressures that many UK GPs currently face, particu-
larly with the implementation of the new GMS GP
contract [20]. All patients are therefore being recruited
from the EIS.
The full support and co-operation of the PCTs, in particu-
lar the Heart of Birmingham PCT who enabled the study
team to use the bi-monthly PCT protected learning time
session to deliver the video based education, was also key
to the success of implementing the intervention.
Strengths
The practice recruitment and retention rates were excel-
lent, ensuring the generalisability of the study findings.
Seventy-eight out of 89 eligible practices were recruited, a
response rate of 87.6%. To date, there has been a low
drop-out rate (one practice). We used a stratified-cluster
design [32] to ensure a balanced randomisation for social
deprivation, which we believe may affect patient-level
outcomes. We are recruiting patients directly from special-
ist secondary care services, and patient outcomes are
based on structured interviews and self-report. The GPs
positively evaluated key elements of the initial education
video and refresher education, and the good attendance at
both these events suggests that this educational interven-
tion is feasible and acceptable in a primary care setting.
Limitations
It was not possible to accurately assess whether the GPs
actually used the written materials that accompanied the
video (booklet and laminated 'tip' sheet) during consulta-
tions. GPs may have disseminated their copy of the writ-
ten materials to control group GPs in their area and the
extent of contamination between intervention and con-
trol group practices is therefore unknown.
Table 3: Practice characteristics at baseline
Intervention Practices (n = 39) Control Practices (n = 39) Practices Declined (n = 11)
Mean practice list size (range) 4200 (924–10377) 4083 (1465–9927) 4149 (1300–9598)
Single-handed practices 17 (44%) 17 (44%) 6 (55%)
Mean No. of senior partners per practice (range) 2.35 (1–8) 2.03 (1–7) 1.81 (1–4)
Total number of GPs 80 67 20BMC Health Services Research 2005, 5:19 http://www.biomedcentral.com/1472-6963/5/19
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Conclusion
FEP is a devastating diagnosis for the individual and their
family. GPs appear to be key players in the referral path-
way into EIS and therefore play an important role in the
early identification of FEP and potentially in reducing
DUP. The Redirect trial, which will report in 2006, will
provide robust information about the efficacy of an evi-
dence-based complex educational intervention targeted at
GPs on referral rates of young people with FEP to EIS.
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